Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Vaccines

  Free Subscription


22.09.2025

1 Ann Intern Med
1 BMJ
2 J Virol
1 MMWR Morb Mortal Wkly Rep
2 PLoS One
1 Proc Natl Acad Sci U S A
36 Vaccine


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Intern Med

  1. LAINE C, Turner BJ, Qaseem A, Moyer DV, et al
    Vaccines: Decision Making Amid Conflicting Recommendations.
    Ann Intern Med. 2025 Sep 16. doi: 10.7326/ANNALS-25-04054.
    PubMed        


    BMJ

  2. IACOBUCCI G
    mRNA vaccines and cancer: Experts warn of misinformation as Malhotra row goes mainstream.
    BMJ. 2025;390:r1934.
    PubMed        


    J Virol

  3. PAPPAS C, Brock N, Belser JA, Kieran TJ, et al
    Identification of clinical and virological correlates associated with influenza A candidate vaccine virus (CVV) attenuation in a ferret model.
    J Virol. 2025 Sep 17:e0102325. doi: 10.1128/jvi.01023.
    PubMed         Abstract available

  4. ZHANG C, Zhou Y-C, Song W-Y, Liu X-X, et al
    Rationally designed self-assembled peptide nanofibers provoke robust humoral immunity against nervous necrosis virus.
    J Virol. 2025;99:e0031925.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  5. O'HALLORAN A, Habeck JW, Gilmer M, Threlkel R, et al
    Influenza-Associated Hospitalizations During a High Severity Season - Influenza Hospitalization Surveillance Network, United States, 2024-25 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2025;74:529-537.
    PubMed         Abstract available


    PLoS One

  6. POKU CA, Owusu GA, Gyamfuah P, Addae G, et al
    Determinants of vaccination uptake among pregnant women in Kumasi: A multi-centre cross-sectional study.
    PLoS One. 2025;20:e0332425.
    PubMed         Abstract available

  7. MARFOH K, Samba A, Okyere E, Fattah AZ, et al
    Post-vaccination SARS-CoV-2 infections among healthcare workers in a tertiary hospital in Ghana.
    PLoS One. 2025;20:e0331971.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  8. SWINGLE KL, Hamilton AG, Han X, Liao KC, et al
    Circular RNA lipid nanoparticle vaccine against SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2025;122:e2505718122.
    PubMed         Abstract available


    Vaccine

  9. SSALI A, Nalubega P, Namugumya R, Kyohere M, et al
    Pregnant and breastfeeding women concerns during a group B Streptococcus phase ll clinical trial: A qualitative study in Kampala, Uganda.
    Vaccine. 2025;62:127592.
    PubMed         Abstract available

  10. PROCIANOY GS, Silveira RC, Procianoy RS
    Impact of the May 2024 floods on childhood immunization coverage in Rio Grande do Sul, Brazil.
    Vaccine. 2025;62:127573.
    PubMed         Abstract available

  11. ENGLISH S, Fedosyuk S, Orliacq F, Tem V, et al
    Rabies glycoprotein engineering for improved stability and expression.
    Vaccine. 2025;62:127541.
    PubMed         Abstract available

  12. SALOMAO MDG, de Almeida Leitao Curimbaba C, Braga PE, Franca JID, et al
    Long-term efficacy and immune response of CoronaVac in Brazilian health care workers: Insights from PROFISCOV unblinded trial.
    Vaccine. 2025;62:127527.
    PubMed         Abstract available

  13. VAN DER WEG W, von Kreijfelt G, Davidson L, Zwaveling J, et al
    Strengthening spontaneous reporting-based signal detection during a pandemic with cases from electronic health records using a natural language processing tool.
    Vaccine. 2025;62:127549.
    PubMed         Abstract available

  14. SHIBUYA Y
    Culture filtrate proteins from Bacillus Calmette-Guerin.
    Vaccine. 2025;62:127486.
    PubMed         Abstract available

  15. RICHARDSON M, Daneman N, Miller FA, Sander B, et al
    Moving from intervention management to disease management for Clostridioides difficile infection: an economic evaluation exploring the impact of a systems approach to health technology assessment.
    Vaccine. 2025;62:127512.
    PubMed         Abstract available

  16. BROAD J, Letley L, Adair G, Walker J, et al
    An England-wide survey on attitudes towards antenatal and infant immunisation against respiratory syncytial virus amongst pregnant and post-partum women.
    Vaccine. 2025;62:127482.
    PubMed         Abstract available

  17. ARIYARAJAH A, Crowcroft NS, Brown KA, Wang J, et al
    Measles seroprevalence among individuals serologically tested in Ontario, Canada.
    Vaccine. 2025;62:127446.
    PubMed         Abstract available

  18. WAGNER SB, Rincon M, Keen KE, Hawk GS, et al
    SARS-CoV-2 breakthrough infection during pregnancy preferentially elicits IgG4 response and enhanced placental-transfer.
    Vaccine. 2025;62:127476.
    PubMed         Abstract available

  19. SANO K, Miyakawa K, Kato H, Kimura Y, et al
    Neutralizing antibody evasion of SARS-CoV-2 JN.1 derivatives KP.3, KP.3.1.1, LB.1, and XEC.
    Vaccine. 2025;62:127472.
    PubMed         Abstract available

  20. BAUSSANO I, Tenet V, Baghdasarova K, Harutyunyan Z, et al
    HPV burden in Armenia among unvaccinated women: a series of cross-sectional population-based prevalence surveys.
    Vaccine. 2025;62:127405.
    PubMed         Abstract available

  21. WANG J, Zhao W, Bai S, Zhang A, et al
    Different patterns of antimicrobial non-susceptibility of the nasopharyngeal carriage of Streptococcus pneumoniae in areas with high and low levels of PCV13 coverage.
    Vaccine. 2025;62:127455.
    PubMed         Abstract available

  22. SCHMITT MM, Rossler A, Netzl A, Knabl L, et al
    Exposure to two antigenically distinct SARS-CoV-2 variants broadens neutralization patterns.
    Vaccine. 2025;62:127459.
    PubMed         Abstract available

  23. PIERCE SR, Shi H, Caetano C, Prots DA, et al
    Self-amplifying mRNA expressing COBRA hemagglutinin elicits long-lasting, broadly reactive antibodies against seasonal influenza A viruses.
    Vaccine. 2025;62:127449.
    PubMed         Abstract available

  24. SHEN Y, Sung MH, Ge Y, Chen Y, et al
    Predicting influenza vaccine-elicited antibody responses with practical point systems.
    Vaccine. 2025;64:127737.
    PubMed         Abstract available

  25. PIAL RH, Capeding MR, Tadesse BT, Excler JL, et al
    Longevity of immune-response provided by at least one dose of vi-DT vaccine 5 years after vaccination among healthy Filipino adults and children.
    Vaccine. 2025;64:127751.
    PubMed         Abstract available

  26. INOUE S, Fuji K
    The mutual cyclical influence of internet information and vaccination intention on post-dissemination vaccination: A longitudinal study during the availability period of COVID-19 booster shots.
    Vaccine. 2025;64:127741.
    PubMed         Abstract available

  27. HAMONIC G, Pastural E, Arora S, Lew J, et al
    Safety and immunogenicity of COVAC-2, a Sepivac SWE adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trial.
    Vaccine. 2025;64:127748.
    PubMed         Abstract available

  28. RAMACHANDRAN V, Tangney S, Gedlinske A, Askelson NM, et al
    Pneumococcal vaccination knowledge, attitudes, and practices among surveyed U.S. adults aged 19-64 years at increased risk for pneumococcal disease.
    Vaccine. 2025;64:127739.
    PubMed         Abstract available

  29. ODAGIRI T, Yoshino N, Sasaki Y, Ishikawa S, et al
    Polymyxin B as a novel mucosal adjuvant for the intranasal whole inactivated influenza vaccine.
    Vaccine. 2025;64:127750.
    PubMed         Abstract available

  30. TURJEMAN A, Shochat T, Drozdinsky G, Leibovici L, et al
    Disparities and temporal trends in pneumococcal vaccination uptake among older adults in the Israeli population: A population-based retrospective cohort study.
    Vaccine. 2025;64:127765.
    PubMed         Abstract available

  31. SEGEL JE, Luan P, Ramos ML, Zaorsky NG, et al
    Drivers of HPV vaccination rates among adolescent dependents in the military health system.
    Vaccine. 2025;64:127753.
    PubMed         Abstract available

  32. VAN BEEK LF, He X, Koks MS, van der Gaast-de Jongh CE, et al
    Comparing the immunogenicity of intradermal and intramuscular vaccination of elderly with BNT162b2 XBB.1.5: An equivalent dose study.
    Vaccine. 2025;64:127749.
    PubMed         Abstract available

  33. MANAQUIN R, Desmoulin A, Luong Nguyen LB, Kornblum D, et al
    Acceptance of chikungunya vaccination: a rapid survey in Reunion island during an epidemic.
    Vaccine. 2025;64:127720.
    PubMed         Abstract available

  34. LANE A, Quach HQ, Ovsyannikova IG, Kennedy RB, et al
    High-resolution antibody dynamics following influenza vaccination reveal predominantly weak responses as well as infrequent but durable immunity across the 2014-2022 seasons.
    Vaccine. 2025 Sep 12:127677. doi: 10.1016/j.vaccine.2025.127677.
    PubMed         Abstract available

  35. SCHUE JL, Fesshaye B, Miller ES, Singh P, et al
    Examining the role of influence and trust in information sources on the COVID-19 vaccine decision-making process for pregnant and postpartum women in Brazil, Ghana, Kenya, and Pakistan: A mixed methods study.
    Vaccine. 2025 Sep 12:127721. doi: 10.1016/j.vaccine.2025.127721.
    PubMed         Abstract available

  36. HUANG W, Xu M, Diao Z, Chen J, et al
    Vaccination coverage by age 24 months among children born in 2020 and 2021 in China, during the COVID-19 pandemic: A study based on the national immunization information system.
    Vaccine. 2025;64:127717.
    PubMed         Abstract available

  37. KANG W, Wang F, Hao Z, Zhang Z, et al
    A follow-up study on the protective efficacy and anamnestic response of recombinant CHO hepatitis B vaccine 26 years after immunization.
    Vaccine. 2025;64:127743.
    PubMed         Abstract available

  38. YANG Y, Jin SW, Lee S, Lartey S, et al
    Understanding vaccine willingness in post-COVID America: Key determinants and demographic differences.
    Vaccine. 2025;64:127740.
    PubMed         Abstract available

  39. KORVES C, Kulldorff M, Balajee AS, Smith J, et al
    Innovative use of self-controlled methods for the evaluation of waning effectiveness of the COVID-19 monovalent third dose: comparison with a test-negative design.
    Vaccine. 2025;63:127658.
    PubMed         Abstract available

  40. LOUTH J, Holland A, Chum C, Morgan L, et al
    Understanding the immunity gap for serogroup B invasive meningococcal disease due to non-pharmaceutical interventions during the Covid-19 pandemic.
    Vaccine. 2025;63:127647.
    PubMed         Abstract available

  41. GOLLUB EL, Myszkowski N, Xi M, Boyraz G, et al
    Correlates of higher trust in public health officials: results from a representative cohort of private university undergraduates.
    Vaccine. 2025;63:127610.
    PubMed         Abstract available

  42. ZHAO Y, Li G, Li Q, Shi H, et al
    Identification and evaluation of cross-protection efficiency of the conserved antigens of Salmonella Enteritidis.
    Vaccine. 2025;62:127622.
    PubMed         Abstract available

  43. STIMPSON JP, Tamirisa K, Morenz AM, Adhikari EH, et al
    Trust typologies and HPV awareness in the U.S.: a latent class analysis.
    Vaccine. 2025;62:127606.
    PubMed         Abstract available

  44. WU X, Xing J, Tang X, Sheng X, et al
    Temporal transcriptome analysis of head kidney revealed protective cellular immunity in flounder (Paralichthys olivaceus) immunized with inactivated Edwardsiella piscicida.
    Vaccine. 2025;62:127613.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.